New patent expiration for Astrazeneca drug DALIRESP

Annual Drug Patent Expirations for DALIRESP Daliresp is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are three patents protecting…

The post New patent expiration for Astrazeneca drug DALIRESP appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog